Association between transforming growth factor beta 1 and progression-free survival in breast cancer.

被引：0
|
作者：
Yang, George Ruochen [1 ]
Takita, Cristiane [1 ]
Wright, Jean L. [2 ]
Reis, Isildinha M. [1 ]
Lee, Eunkyung [3 ]
Hu, Jennifer J. [1 ]
机构：
[1] Univ Miami, Sch Med, Miami, FL USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ Cent Florida, Miami, FL USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
897
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A transforming growth factor beta 1 polymorphism is protective against breast cancer.
    Kaklamni, VG
    Bian, Y
    Reich, J
    Hou, N
    Rademaker, A
    Pasche, B
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S82 - S82
  • [2] Progression-free survival as a surrogate for overall survival in advanced cancer.
    Gillies, Eric
    Holdai, Veera
    Cowall, David Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Improved progression-free survival in metastatic breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (02): : E79 - E79
  • [4] Prolonged progression-free survival in metastatic breast cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 378 - 378
  • [5] Progesteron receptor status as a predictor of progression-free survival and overall survival in patients with early breast cancer.
    Latiano, T.
    D'Addetta, C.
    Murgo, R.
    Piano, A.
    Morritti, M.
    Valori, V.
    Lombardi, L.
    Parrella, P.
    Copetti, M.
    Maiello, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Transforming growth factor-beta dependent regulation in breast cancer progression
    Kim, Hye Ok
    Song, Junkyu
    Cho, Chang Hoon
    Yoon, Kyung-Sik
    CANCER RESEARCH, 2010, 70
  • [7] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [8] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [9] Association between severe neutropenia and progression-free survival in patients with advanced or recurrent breast cancer treated with palbociclib
    Kimura, M.
    Usami, E.
    Yoshimura, T.
    PHARMAZIE, 2020, 75 (12): : 662 - 665
  • [10] Clinical significance of serum transforming growth factor beta 1 (TGFB1) level in breast cancer.
    Ciftci, Rumeysa
    Tas, Faruk
    Kilic, Leyla
    Vatansever, Sezai
    Karabulut, Senem
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345